WSA
PTX

Wall Street Associates’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Wall Street Associates’s Portfolio PTX Stock Details PTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-27,460
Closed -$288K – 241
2016
Q1 		$288K Sell
27,460
-42,170
-61% -$838K 0.12% 185
2015
Q4 		$2.05M Hold
69,630
– – 0.58% 55
2015
Q3 		$2.2M Sell
69,630
-51,910
-43% -$2.48M 0.42% 77
2015
Q2 		$7.2M Sell
121,540
-2,160
-2% -$152K 0.68% 48
2015
Q1 		$13.2M Sell
123,700
-2,250
-2% -$214K 1.25% 11
2014
Q4 		$11.8M Buy
125,950
+9,780
+8% +$933K 1.13% 11
2014
Q3 		$8.92M Sell
116,170
-6,330
-5% -$498K 0.92% 22
2014
Q2 		$11M Buy
+122,500
New +$7.51M 0.94% 21

Other funds holding PTX

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
GC
Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Wall Street Associates's PTX Position: Q2 2016 in Review

Wall Street Associates sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q2 2016, closing a stake of 27,460 shares — an estimated $288K sold.

Wall Street Associates first reported a position in PTX in Q2 2014 and held it in 8 quarters. The position peaked at $13.2M in Q1 2015. 56 funds tracked by Wall St. Rank hold PTX as of Q2 2016.

  • Wall Street Associates reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q2 2016 after selling out during the quarter.
  • Wall Street Associates sold 27,460 Pernix Therapeutics Holdings, Inc. shares in Q2 2016, an estimated $288K.
  • Wall Street Associates first reported a position in Pernix Therapeutics Holdings, Inc. in Q2 2014 and held it in 8 quarters.
  • Wall Street Associates's Pernix Therapeutics Holdings, Inc. position peaked at $13.2M in Q1 2015.
  • 56 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q2 2016.

Based on Wall Street Associates's 13F filing for Q2 2016, filed 12 Aug 2016.